Connection

RADEK SKODA to Polycythemia

This is a "connection" page, showing publications RADEK SKODA has written about Polycythemia.
Connection Strength

1.506
  1. A Gain-of-Function Mutation in EPO in Familial Erythrocytosis. N Engl J Med. 2018 03 08; 378(10):924-930.
    View in: PubMed
    Score: 0.562
  2. JAK2 exon 12 mutant mice display isolated erythrocytosis and changes in iron metabolism favoring increased erythropoiesis. Blood. 2016 08 11; 128(6):839-51.
    View in: PubMed
    Score: 0.498
  3. Identification of Hepatic-like EPO as a Cause of Polycythemia. N Engl J Med. 2025 May 01; 392(17):1684-1697.
    View in: PubMed
    Score: 0.230
  4. Erythropoietin receptor mutation--a rush of blood to the head? Ann Hematol. 2015 Jul; 94(7):1229-31.
    View in: PubMed
    Score: 0.114
  5. Chronic myeloproliferative disorders: molecular markers and pathogenesis. Hematol J. 2004; 5 Suppl 3:S122-5.
    View in: PubMed
    Score: 0.053
  6. Stalled cerebral capillary blood flow in mouse models of essential thrombocythemia and polycythemia vera revealed by in vivo two-photon imaging. J Thromb Haemost. 2014 Dec; 12(12):2120-30.
    View in: PubMed
    Score: 0.028
  7. Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations. Blood. 2011 Mar 10; 117(10):2813-6.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.